Consistent with this possibility, analyses in head and neck squamous cell carcinoma, breast carcinoma, laryngeal carcinoma and urothelial carcinoma have implicated SH3GL2 as a candidate tumor suppressor [18], [33], [34], [35]. Here, SH3GL2 is linked to urothelial carcinoma.